Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Sakuya, Ito"'
Autor:
Sakuya Ito, Yosuke Nakayama, Goh Kodama, Kanji Ota, Kensei Taguchi, Yusuke Kaida, Sho-ichi Yamagishi, Kei Fukami
Publikováno v:
Renal Replacement Therapy, Vol 7, Iss 1, Pp 1-7 (2021)
Abstract Background Some types of antihypertensive drugs may have pleiotropic effects in patients with chronic kidney disease (CKD). However, whether triple combination therapy with angiotensin II receptor blockers (ARBs), calcium channel blockers (C
Externí odkaz:
https://doaj.org/article/3431b0f383f847698cb1d45549a1a913
Autor:
Yuka Kurokawa, Yusuke Kaida, Takuma Hazama, Yosuke Nakayama, Takaomi Otome, Ryo Shibata, Sakuya Ito, Goh Kodama, Nao Nakamura, Takatoshi Kambe, Tomofumi Moriyama, Akiko Nagata, Aki Minami, Ryotaro Ando, Yoshifumi Wada, Miki Sugiyama, Michiaki Usui, Michio Chiba, Atsuo Moriyama, Atsuko Ohara, Hiroshi Miyazaki, Tatsuyuki Kakuma, Kei Fukami
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-10 (2020)
Abstract Background Etelcalcetide is the first intravenously administered calcimimetic agent used to manage secondary hyperparathyroidism (SHPT) in hemodialysis (HD) patients. We evaluated the safety and efficacy of replacing cinacalcet with etelcalc
Externí odkaz:
https://doaj.org/article/44fc4637fec249aab21820b2c2f391c2
Autor:
Junko Yano, Yusuke Kaida, Yosuke Nakayama, Sakuya Ito, Yuka Kurokawa, Nao Nakamura, Takuma Hazama, Takashi Maeda, Ryuki Hashida, Kyoko Tashiro, Takahiro Inokuchi, Hiroo Matsuse, Kei Fukami
Publikováno v:
Renal Replacement Therapy, Vol 5, Iss 1, Pp 1-6 (2019)
Abstract Background and aim Carnitine deficiency is common and associated with muscle atrophy in hemodialysis (HD) patients. We investigated whether carnitine levels could be an independent predictor for exercise capacity in these patients. Method A
Externí odkaz:
https://doaj.org/article/eac2bde917854560ad959c7a8dc950d4
Publikováno v:
Internal Medicine; 2023, Vol. 62 Issue 21, p3203-3207, 5p
Publikováno v:
Journal of Hypertension. 41:e374-e375
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afbe95d5d4a362690e7f0a68b068433e
https://doi.org/10.1097/01.hjh.0000916636.41543.d1
https://doi.org/10.1097/01.hjh.0000916636.41543.d1
Autor:
Kei Fukami, Goh Kodama, Sho-ichi Yamagishi, Sakuya Ito, Yosuke Nakayama, Kensei Taguchi, Kanji Ota, Yusuke Kaida
Publikováno v:
Renal Replacement Therapy, Vol 7, Iss 1, Pp 1-7 (2021)
Background Some types of antihypertensive drugs may have pleiotropic effects in patients with chronic kidney disease (CKD). However, whether triple combination therapy with angiotensin II receptor blockers (ARBs), calcium channel blockers (CCBs), and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ec3ce397e05de98d82426c75e8a5bf2
https://doaj.org/article/3431b0f383f847698cb1d45549a1a913
https://doaj.org/article/3431b0f383f847698cb1d45549a1a913
Autor:
Aki Minami, Takuma Hazama, Tatsuyuki Kakuma, Akiko Nagata, Kei Fukami, Ryo Shibata, Miki Sugiyama, Yoshifumi Wada, Nao Nakamura, Yusuke Kaida, Ryotaro Ando, Michio Chiba, Sakuya Ito, Atsuko Ohara, Atsuo Moriyama, Michiaki Usui, Yosuke Nakayama, Tomofumi Moriyama, Goh Kodama, Takaomi Otome, Yuka Kurokawa, Hiroshi Miyazaki, Takatoshi Kambe
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-10 (2020)
Background Etelcalcetide is the first intravenously administered calcimimetic agent used to manage secondary hyperparathyroidism (SHPT) in hemodialysis (HD) patients. We evaluated the safety and efficacy of replacing cinacalcet with etelcalcetide in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f0375ca161c9872b89b845383b2e102
https://doaj.org/article/44fc4637fec249aab21820b2c2f391c2
https://doaj.org/article/44fc4637fec249aab21820b2c2f391c2
Autor:
Hiroo Matsuse, Ryo Shibata, Junko Yano, Yusuke Kaida, Takuma Hazama, Takaomi Otome, Ryuki Hashida, Yuka Kurokawa, Kyoko Tashiro, Yosuke Nakayama, Shuji Nagata, Takashi Maeda, Sakuya Ito, Tatsuyuki Kakuma, Kei Fukami, Tatsuyuki Tonan
Publikováno v:
Therapeutic Apheresis and Dialysis
Serum carnitine is decreased in hemodialysis patients, which induces muscle atrophy. Thus, we examined the different effects of l‐carnitine and exercise on exercise activity and muscle status in hemodialysis patients. Twenty patients were divided i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4387203f0725471a68b2caff5a6647af
http://europepmc.org/articles/PMC8247310
http://europepmc.org/articles/PMC8247310
Autor:
Tomofumi Moriyama, Kensei Taguchi, Yusuke Kaida, Sakuya Ito, Goh Kodama, Yunosuke Yokota, Makoto Nasu, Kei Fukami
Publikováno v:
Journal of Hypertension. 41:e417
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::982c03eeda4dc06572e51f6f8227cecd
https://doi.org/10.1097/01.hjh.0000917104.10733.81
https://doi.org/10.1097/01.hjh.0000917104.10733.81
Publikováno v:
Journal of Hypertension. 41:e443
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60737d10824d150b94e051c06bf5331d
https://doi.org/10.1097/01.hjh.0000917384.68636.0e
https://doi.org/10.1097/01.hjh.0000917384.68636.0e